Description: RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Home Page: rls.global
Neongatan 5
Mölndal,
431 53
Sweden
Phone:
46 3 17 80 68 20
Officers
| Name | Title |
|---|---|
| Mr. Bjorn Larsson | CEO & Member of Management Board |
| Ms. Eva Jagenheim | CFO & Member of Management Board |
| Mr. Anders Husmark | Chief Bus. Devel. Officer & Member of Management Board |
| Mr. Magnus Nolmark | COO & Member of Management Board |
| Susanne Olausson | CTO & Member of Management Board |
| Magnus Olsson | Head of Sales & Marketing |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 14.3402 |
| Price-to-Sales TTM: | 184.1267 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 9 |